- Filed
- Nov 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 31, 2025 | 20.34M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 18.95M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 15.72M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 13.95M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 13.62M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $0 |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $3M |
| Capex | Q3 2025 · Sep 30, 2025 | $153K |
| Capex | Q3 2025 · Sep 30, 2024 | $1.01M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$143.55M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$129.52M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $41.03M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $44.25M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $85.09M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$24.21M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $13.74M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $60.74M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $48.88M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $79.69M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $126.71M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $130.99M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $66.34M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $61.4M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $216.26M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $243.11M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $281.36M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $261.29M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $301.35M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $303.85M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.87 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$8.14 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$2.66 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$9.27 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.87 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$8.14 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$2.66 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$9.27 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $16.07M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $57.49M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $18.96M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $59.62M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $27.25M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $87.62M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $35.03M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $92.16M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$35.52M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$128M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$37.06M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$126.22M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$31.67M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$112.44M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$34.35M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$119.55M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $0 |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $0 |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $4.44M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $22.71M |
| Revenue | Q3 2025 · Sep 30, 2025 | $11.79M |
| Revenue | Q3 2025 · Sep 30, 2025 | $33.43M |
| Revenue | Q3 2025 · Sep 30, 2024 | $24.12M |
| Revenue | Q3 2025 · Sep 30, 2024 | $69.25M |